Brief: Merus Announces Financial Results For The Q4 And FY 2022 And Provides Business Update

Merus NV

28/02/2023 21:35

Feb 28 (Reuters) - Merus NV  MRUS.O :
    * MERUS ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER
AND
FULL YEAR 2022 AND PROVIDES BUSINESS UPDATE
    * MERUS NV - PETOSEMTAMAB CLINICAL AND REGULATORY UPDATE
PLANNED
FOR FIRST HALF OF 2023
    * MERUS NV - MCLA-129 CLINICAL UPDATE PLANNED FOR SECOND
HALF OF
2023
    * MERUS NV - ZENOCUTUZUMAB (ZENO) IN NRG1+ CANCER POTENTIAL
REGISTRATIONAL PATH AND TIMELINE UPDATE PLANNED FOR FIRST HALF
OF 2023
    * MERUS NV - BASED ON CO'S CURRENT OPERATING PLAN, EXISTING
CASH,
CASH EQUIVALENTS & MARKETABLE SECURITIES EXPECTED TO FUND CO'
OPERATIONS INTO H2 2025

Source text for Eikon:  ID:nGNX5VZRRP 
Further company coverage:  MRUS.O 

 ((Reuters.Briefs@thomsonreuters.com;))